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PAAT: A PATH TO ATHEROSCLEROSIS?
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The artery wall consists of intima, media, and adventitia, the latter gradually transiting into the periadventitial adipose tissue 
(PAAT). Although many paths lead to atherosclerosis, the prevailing paradigm at present is Russell Ross’s response-to-injury 
hypothesis, which states that atherosclerosis is a chronic inflammatory disease. This hypothesis considers the intimal smooth 
muscle cell proliferation as a key event in the generation, development and complication of atherosclerosis. Thus the potentially 
important role played by adventitial fibroblasts/myofibroblasts in atherosclerosis and postangioplasty restenosis, suggesting 
therapeutic perspectives targeted to these particular cells, has been neglected. Here we go further away from the intima, and 
focus on the potential involvement of PAAT in the process of atherogenesis and angioplasty-induced restenosis.
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An artery affected by atherosclerosis displays intimal and ad-
ventitial lesions associated with medial atrophy (1). Although 
many paths lead to atherosclerosis, the prevailing paradigm 
at present is Russell Ross’s response-to-injury hypothesis, 
which states that atherosclerosis is a chronic inflammatory 
disease that involves several aspects of wound healing-like 
vascular remodeling (1,2). This hypothesis proposes endo-
thelial dysfunction, lymphocyte and monocyte extravasation 
into the intima, and vascular smooth muscle cell (VSMC) 
proliferation and oversecretion of matrix molecules (1,3) as 
key events in the generation, development and complications 
of atherosclerotic plaques. Because advanced intimal lesions 
lead to erosion/rupture of plaque surface, resulting in acute 
coronary syndromes, the intima is considered by many authors 
the most important vascular area involved in the process of 
atherogenesis (reviewed in 1,2) . However, growing evidence 
rises the possibility of adventitial pathway of the vascular 
injury response (4-6), suggesting that atherogenesis is not just 
for intima and, respectively, intimal VSMC proliferation. For 
example, the otherwise excellent review (7), published in a spe-
cial section on “Advances in Atherosclerosis” in the November 
2002 issue of Nature Medicine, was a strongly VSMC-centric 
description and perspective in atherosclerosis, angioplasty-
induced restenosis, and transplant vasculopathy. While recent 
findings demonstrate that lumen narrowing is caused in large 
part by a fibrocontractive adventitial scaring (4) and adventitial 
inflammation (8), no specific attention was paid by Dzau et al 
(7)(except their reference 13) to cells, signals and/or reactions 
that may derive from both the adventitia and the periadventitial 
adipose tissue (PAAT), as clearly illustrated in their Figs. 1 and 
3. Meanwhile, in Fig. 3, the authors’ legend “VSMC mediate 
proliferation, inflammation, matrix alterations and contraction” 
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can be replaced by “Myofibroblasts mediate...”, without any 
substantial changes in the Figure. Thus the important role 
played by fibroblasts/myofibroblasts in vascular inflammatory-
fibroproliferative diseases, suggesting therapeutic perspectives 
targeted to these particular cells, has been neglected. 
     Here, “bypassing” the adventitia, we will go further away 
from the intima, and focus on the potential involvement of 
PAAT in atherogenesis and angioplasty-induced restenosis.   
     The artery wall consists of intima, media, and adventitia, 
the latter gradually transiting into the PAAT. Adipose tissue 
is partitioned into few large depots, including subcutaneous 
and visceral location, and many small depots, associated 
with heart, large blood vessels, major lymph nodes, kidneys, 
adrenal glands, bone marrow, and even the brain (reviewed 
in 9). Indeed, the possibility that the endocrine secretory 
activity of large adipose depots may contribute to the altered 
plasma levels in various adipokine-associated diseases 
including cardiovascular disease (10-14) has recently gained 
considerable attention. However, the paracrine secretory 
activity of the small depots has until now attracted little 
attention in the adipobiology of disease. If signals can be 
targeted, via an endocrine pathway, from the large adipose 
depots through the blood circulation towards many organs in 
the body, then why not look for analogous paracrine influence 
from the organ-associated adipose tissue including PAAT? 
   The subepicardial adipose tissue surrounding the most 
proximal and atherosclerosis-prone portion of left anterior 
descending coronary artery is an excellent example of PAAT 
in atherosclerosis. The principle difference between coronary 
PAAT and adipose tissue elsewhere in the body is its greater 
capacity for free fatty acid release and uptake, thus acting as 
a local energy supply for the heart and/or as a buffer against 
toxic levels of free fatty acids (15) and toxic lipid-soluble 
substances that may accumulate in PAAT (16). This tissue the-
refore is “not a passive storehouse for fat”, as stated by Smith 
and Willius in 1933 (see 15). Neglected for nearly 70 years, 
the possible involvement of coronary PAAT in atherogenesis 
has been recently addressed (17-19). In PAAT surrounding 
human atherosclerotic coronary arteries, we have recently 
reported the first evidence for an elevated amount of nerve 
growth factor (NGF)(19), a prototypic member of the protein 
family of neurotrophins which, in addition to its action on dif-
ferentiation and survival of sympathetic and sensory neurons, 
exerts multiple effects on immune and other non-neuronal 
cells (20). This was accompanied by a strong mesenchymal 
reaction by “atherosclerotic” PAAT, consisted of an increased 
number of mast cells, microvessels and connective tissue septa, 
compared to controls. Whether such an increased amount of 
both NGF and mast cells [the latter can produce NGF (20)] 
may represent an intrinsic effort of this tissue to compensate 
the reduced levels of NGF found in atherosclerotic coronary 
vascular tissue (19) and in the blood plasma of patients with 
metabolic syndrome (21), remains to be evaluated. Also to 
be considered is whether the coronary PAAT’s mesenchymal 
reaction in atherosclerosis (17; and present study) may cont-
ribute to lumen narrowing, as suggested for the fibrocontrac-
tive adventitial scaring (4) and adventitial inflammation (8). 
Noteworthy, a recent work demonstrated that PAAT exerts an 
anti-contractile effect in aortic ring preparations, suggesting 
of PAAT-derived relaxing factor(s) (22). This finding reminds 
us the story of endothelium-derived relaxing factor, the now 
well-known nitric oxide. 
    Taken together, these data pressingly suggest that we should 
no longer consider PAAT separately from the respective artery, 
but keep PAAT attached and in place, and subject to thorough 
examination. Applying such an “adipoprotective” strategy, re-
cent studies implicated major lymph node-associated adipose 
tissue in immune responses (23,24). 
     Another reason for subepicardial adipose tissue to serve as 
an excellent example of PAAT in atherogenesis is the close 
association of the coronary vasculogenesis with epicardial 
and subepicardial development, including epicardium-
derived mesenchymal cells invading the subepicardial 
matrix and differentiating into coronary VSMC and peri-
vascular fibroblasts, mediated by the transcription factor 
capsulin/epicardin (25-27). Thus coronary VSMC distinguish 
themselves ontologically, structurally and functionally as 
compared to VSMC in other blood vessels. The heterogeneity 
between these cells may subsequently involve an increased 
susceptibility of the coronary artery to atherosclerosis (28,29). 
Hence the question arises as to whether coronary PAAT may 
also contribute to that? Using capsulin/epicardin-based 
genetically modified mice fed with high-cholesterol diet 
may answer this and related questions. Accordingly, better 
understanding of the proepicardium-mediated coronary 
vasculogenesis may clarify mechansims of cardiovascular 
disease and suggest new therapeutic strategies.
     Overall, these findings support the hypothesis that PAAT 
may represent an important target for studying the adipo-
biology and therapy of atherosclerosis and postangioplasty 
restenosis.
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